Dorthe Grønnegaard Mejer joins FluoGuide A/S as Vice President of Clinical Development
Copenhagen, Denmark, 30 June 2020 – FluoGuide A/S (“FluoGuide” or “the Company”) has recruited Dorthe Grønnegaard Mejer as VP of Clinical Development.The clinical development of FG001 for use to guide surgery of aggressive brain cancer (glioblastoma) can be very short until approval. In order to secure maximal usefulness of the first clinical trial commencing this fall, the Company has recruited Dorthe Grønnegaard Mejer to the position of VP of Clinical Development. Dorthe Grønnegaard Mejer has a Master of Science in Pharmaceutical Sciences from Copenhagen University. She has previously